These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33368448)

  • 1. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
    Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
    Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.
    Kim SG; Cho JM; Han K; Joo KW; Lee S; Kim Y; Cho S; Huh H; Kim M; Kang E; Kim DK; Park S
    BMJ Open; 2024 Jan; 14(1):e078032. PubMed ID: 38286693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
    Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
    Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
    Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
    PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into acute-on-chronic kidney disease in nephrology patients: the CKD-REIN study.
    Hamroun A; Frimat L; Laville M; Metzger M; Combe C; Fouque D; Jacquelinet C; Ayav C; Liabeuf S; Lange C; Herpe YE; Zee J; Glowacki F; Massy ZA; Robinson B; Stengel B;
    Nephrol Dial Transplant; 2022 Aug; 37(9):1700-1709. PubMed ID: 34473306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort.
    Rodríguez-Poncelas A; Barceló MA; Saez M; Coll-de-Tuero G
    PLoS One; 2018; 13(10):e0204231. PubMed ID: 30332411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.
    Grant CH; Gillis KA; Lees JS; Traynor JP; Mark PB; Stevens KI
    QJM; 2019 Nov; 112(11):835-840. PubMed ID: 31251364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
    Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
    J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease.
    El Chamieh C; Larabi IA; Laville SM; Jacquelinet C; Combe C; Fouque D; Laville M; Frimat L; Pecoits-Filho R; Lange C; Stengel B; Alencar De Pinho N; Alvarez JC; Massy ZA; Liabeuf S;
    Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.
    Cholin L; Ashour T; Mehdi A; Taliercio JJ; Daou R; Arrigain S; Schold JD; Thomas G; Nally J; Nakhoul NL; Nakhoul GN
    BMC Nephrol; 2021 Jul; 22(1):264. PubMed ID: 34266395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographic and health-related predictors of proton pump inhibitor (PPI) use and association with chronic kidney disease (CKD) stage in NHANES population.
    Devraj R; Deshpande M
    Res Social Adm Pharm; 2020 Jun; 16(6):776-782. PubMed ID: 31445985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD.
    Laville SM; Gras-Champel V; Hamroun A; Moragny J; Lambert O; Metzger M; Jacquelinet C; Combe C; Fouque D; Laville M; Frimat L; Robinson BM; Bieber B; Stengel B; Alencar De Pinho N; Massy ZA; Liabeuf S;
    Am J Kidney Dis; 2024 May; 83(5):601-614.e1. PubMed ID: 37951340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
    Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
    Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort.
    Dos Santos AS; de Menezes ST; Silva IR; Oliveira WN; Pereira ML; Mill JG; Barreto SM; Figueiredo RC
    BMC Nephrol; 2023 Sep; 24(1):285. PubMed ID: 37770872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
    Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.